Document Detail

Methicillin-resistant Staphylococcus aureus versus the burn patient.
MedLine Citation:
PMID:  9625231     Owner:  NLM     Status:  MEDLINE    
Methicillin-resistant Staphylococcus aureus (MRSA) has become a frequent cause of nosocomial infection, its increasing prevalence posing serious therapeutic and infection control problems within the hospital environment. MRSA is a major challenge to the burn patient, with potential to cause significant morbidity and mortality. Burn patients have been shown to become colonised and infected more readily than other patient groups. Extensive burn injuries are particularly susceptible to infection as a result of the disruption of the normal skin barrier and accompanying depression of immune responses. Extended hospitalisation and antibiotic therapy have been identified as additional risk factors for MRSA carriage and infection. Microbial surveillance, epidemiological studies and the introduction of strict infection control regimes can reduce the prevalence of MRSA but may be insufficient for eradication or prevention of outbreak situations. Recognition of the clinical importance of MRSA to the burn patient highlights the need to take appropriate measures to minimise transmission and infection in this vulnerable group of patients.
N Cook
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Burns : journal of the International Society for Burn Injuries     Volume:  24     ISSN:  0305-4179     ISO Abbreviation:  Burns     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-08-04     Completed Date:  1998-08-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8913178     Medline TA:  Burns     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  91-8     Citation Subset:  IM    
Centre for Applied Microbiology and Research, Salisbury, Wilshire, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Burns / drug therapy,  microbiology*
Methicillin / therapeutic use*
Methicillin Resistance*
Penicillins / therapeutic use
Staphylococcal Infections / drug therapy,  epidemiology,  microbiology*
Staphylococcus aureus / drug effects*,  pathogenicity
Wound Infection / drug therapy,  epidemiology,  microbiology*
Reg. No./Substance:
0/Penicillins; 61-32-5/Methicillin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychiatric comorbidity in patients with burning mouth syndrome.
Next Document:  Characterization of acellular dermal matrices (ADMs) prepared by two different methods.